of human brain and tumor capillaries following bar rier disruption with 1.37 M mannitol.
Letters to the Editor

BLOOD-TUMOR BARRIER DISRUPTION CONTROVERSIES
To the Editor: The recent article by Robinson and Rapoport (1990) deserves comment more for what is omitted than what is included in the article. As the authors' point out, the efficacy of osmotic bar rier disruption in brain tumor chemotherapy is con troversial (Fishman, 1987 (Fishman, , 1988 Rapoport, 1988; Shapiro, 1988; Groothuis and Blasberg, 1988) . This paper contributes to the controversy. The major point of our concern is the selection of data the authors chose for their modeling analysis. To clarify this point, the following facts should be brought to the attention of the readership: (a) Disruption of the blood-brain and blood-tumor barriers in human subjects and in most experimental animal studies is performed by intracarotid artery infusions of 1. 37 M mannitol or its equivalent. (b) The values for the blood-brain transfer coefficients (K]) that were used in the modeling analysis of Robinson and Rap oport were obtained from animals treated with in tracarotid artery infusions of 1. 6 M mannitol (Hiesiger et aI. , 1986) . (c) What is not mentioned or discussed by Robinson and Rapoport is that corre sponding studies using 1. 37 M mannitol were also performed and reported by Hiesiger et al. (1986) . Additional barrier disruption studies using 1. 37 M mannitol (or its equivalent) in other tumor-bearing rats and tumor-bearing dogs have also been re ported (Nakagawa et aI. , 1984; Warnke et aI. , 1987; and Groothuis et aI. , 1990) and recently reviewed (Blasberg et aI. , 1990) . We suggest that the K] val ues following barrier disruption with 1. 37 M mannitol in tumor-bearing animals are more likely to reflect the extent of barrier disruption in human subjects receiving 1. 37 M mannitol intracarotid in fusions just prior to chemotherapy for brain tumors. (d) The transfer coefficients before and after intra carotid artery infusions of 1. 37 and 1. 6 M mannitol in tumor-bearing rats are given in Table 1 (Hiesiger et ai, 1986) . The small differences in K] observed in tumor and brain surrounding tumor (BST) after bar rier disruption with 1. 37 M mannitol were not sta tistically significant. (e) It is apparent from Table 1 that barrier disruption with 1. 6 M mannitol is con siderably more effective than that with 1. 37 M man nitol. However, an intracarotid artery infusion of 1. 6 M mannitol is not a benign procedure in rats. Robinson and Rapoport do not mention the 25% and 60% mortality of animals that was reported by the investigators who performed these experiments (Hiesiger et aI. , 1986) . lntracarotid artery infusions of 1. 6 M mannitol have not been performed in hu man subjects to the best of our knowledge.
As stated previously by Groothuis and Blasberg (1988) , "We do not think it is correct to discuss the efficacy of barrier disruption using 1. 6 M mannitol in rats and the safety of barrier disruption using 1. 37 M mannitol in patients. This is particularly evident when only a small or negligible effect on the perme ability of tumor capillaries in rats has been demon strated with 1. 37 M mannitol." Unfortunately, the article by Robinson and Rapoport does not address or mention these issues. We conclude that the mod eling analysis of Robinson and Rapoport using the data obtained following barrier disruption with 1.6 M mannitol in rats is not likely to be representative To the Editor: Blasberg and Groothuis ask why we did not discuss a particular set of published data on osmotic opening of the blood-brain barrier (BBB) in animals with brain tumors (Robinson and Rapoport, 1990) , namely the data of Hiesiger et al. (1986) using 1.37 M, equal to 1.6 molal, mannitol. Our publication was not a review of the literature, but rather an elaboration of a mathematical model involving parameters such as permeability at the J Cereb Blood Flow Metab, Vol. 11, No.1, 1991 BBB and blood-tumor barrier, and tissue diffusion, before and after osmotic opening. We chose only one experimental example to illustrate the princi ples of this model, and did not believe it necessary to also consider results with 1.37 M mannitol by Hiesiger et al. (1986) , our own data, nor many other published results. If they wish, Blasberg and Groothuis can easily apply our model to any results of special interest to them.
The suggestion of the Blasberg and Groothuis let ter is that carotid infusion of 1.37 M mannitol must produce the same barrier effects in all species and under all experimental conditions, and therefore that this solution is as ineffective in the clinic as it was in the rats studied by Hiesiger et al. (1986) . We disagree with their assumption, and the logic be hind it.
One reason is that infusate tonicity is not equiv alent to the tonicity to which the BBB at cerebral capillaries actually is exposed. Several factors, in cluding type of anesthetic, solution viscosity, and species differences in the diameter of the carotid vasculature, can influence infusate dilution by sys temic blood. The capillary concentration of infusate may be as little as one-half of the infusate concen tration during the osmotic procedure, as shown by experiments in which e4C]iodoantipyrine was in fused intravenously to measure cerebral blood flow during carotid infusion (Rapoport et aI., 1980) . Under standardized conditions with hypertonic arabinose in barbiturate-anesthetized rats, the max imum reversible osmotic opening of the BBB oc curs once a threshold tonicity is reached at a given infusion time, as illustrated in Fig. 1 (Rapoport et aI., 1980) . Thus, a 1.6 molal arabinose solution, in fused for 30 s into the carotid circulation, has the same BBB consequences as does a 1.8 molal solu tion, whereas a 1.4 molal solution is largely ineffec tive. At the capillary level, it is likely that arabinose concentrations are diluted but nevertheless propor tional to respective infusate concentrations.
The BBB effect of 1.37 M mannitol is maximal in rats anesthetized with phenobarbital, ketamine xylazine, isoflurane, methoxyflurane-phenyleph rine, or fentanyl-droperidol-propranolol (Gum erlock and Neuwelt, 1990) . However, animals anesthetized with methoxyflurane or fentanyldro peridol show a minimal opening, and are either more hypotensive or tachycardic than animals anes thetized with phenobarbital. It would appear that the capillary concentration of mannitol is reduced in the presence of each of these two anesthetics.
BBB opening with 1.6 molal arabinose in barbit urate-anesthetized rats is maximal and entirely re-
